AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 18191483 — intervention group
Group type: EXPERIMENTAL
Intervention: 12-lead electrocardiogram (ECG) patterns: ST-elevation ≥0.5 mm in lead aVL or any ST-elevation in lead aVR with precordial ST-segment elevation in at least two contiguous leads (including V2, V3, or V4)
Number of subjects: 146
Study 18191483 — intervention group
Group type: EXPERIMENTAL
Intervention: ECG or angiographic signs of lesion proximality
Number of subjects: 146
Study 17261575 — intervention group
Group type: EXPERIMENTAL
Intervention: Day 3 blastomere biopsy, day 5 transfer (Group A)
Number of subjects: 20
Study 17261575 — intervention group
Group type: EXPERIMENTAL
Intervention: Day 5 trophectoderm biopsy, day 6 transfer (Group B)
Number of subjects: 20
Study 17261575 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall results
Number of subjects: 20
Study 14750002 — intervention group
Group type: EXPERIMENTAL
Intervention: Sweetened matrix formulation of OTFC (200 microg fentanyl)
Number of subjects: 14
Study 14750002 — intervention group
Group type: EXPERIMENTAL
Intervention: Compressed powder formulation of OTFC (200 microg fentanyl)
Number of subjects: 14
Study 14750002 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study 11837468 — intervention group
Group type: EXPERIMENTAL
Intervention: Glibenclamide (Group I)
Number of subjects: 50
Study 11837468 — intervention group
Group type: COMPARATOR
Intervention: Gliclazide (Group II)
Number of subjects: 50
Study 9926788 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified laparoscopic intraperitoneal onlay mesh herniorrhaphy (IPOM) using a meshed expanded polytetrafluorethylene (ePTFE) soft tissue patch
Number of subjects: 58
Study 9926788 — intervention group
Group type: COMPARATOR
Intervention: Conventional anterior inguinal herniorrhaphy (CH)
Number of subjects: 58
Study 9926788 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified laparoscopic intraperitoneal onlay mesh herniorrhaphy (IPOM)
Number of subjects: 58
Study 9926788 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 58
Study 7803737 — intervention group
Group type: EXPERIMENTAL
Intervention: Bard bubble oxygenator H1700
Number of subjects: 500
Study 7803737 — intervention group
Group type: COMPARATOR
Intervention: Bard membrane oxygenator HF5700
Number of subjects: 500
Study 3407893 — intervention group
Group type: EXPERIMENTAL
Intervention: modified neuroleptanesthesia with midazolam, fentanyl, and vecuronium
Number of subjects: 20
Study 3407893 — intervention group
Group type: EXPERIMENTAL
Intervention: isoflurane anesthesia with vecuronium relaxation
Number of subjects: 20
Study 3407893 — intervention group
Group type: COMPARATOR
Intervention: Control group (not explicitly defined)
Number of subjects: 20
Study 31094428 — intervention group
Group type: EXPERIMENTAL
Intervention: Revised WIC Food Package (including more whole grains, fruits, vegetables, and low-fat milk)
Number of subjects: 1454
Study 31094428 — intervention group
Group type: COMPARATOR
Intervention: Control group (non-recipients)
Number of subjects: 1454
Study 28832197 — intervention group
Group type: EXPERIMENTAL
Intervention: Bilateral views without training
Number of subjects: 82
Study 28832197 — intervention group
Group type: EXPERIMENTAL
Intervention: Bilateral views with training
Number of subjects: 82
Study 28832197 — intervention group
Group type: COMPARATOR
Intervention: Unilateral views without training
Number of subjects: 82
Study 28832197 — intervention group
Group type: COMPARATOR
Intervention: Unilateral views with training
Number of subjects: 82
Study 25819480 — intervention group
Group type: EXPERIMENTAL
Intervention: Diabetes regimen distress (RD) intervention
Number of subjects: 392
Study 25819480 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 392
Study 23804544 — intervention group
Group type: EXPERIMENTAL
Intervention: OLD-FRAME: choose which item is 'older'
Number of subjects: 0
Study 23804544 — intervention group
Group type: COMPARATOR
Intervention: NO-FRAME: choose which item is 'correct'
Number of subjects: 0
Study 23804544 — intervention group
Group type: EXPERIMENTAL
Intervention: Hierarchy recall accuracy
Number of subjects: 0
Study 23804544 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional awareness scores
Number of subjects: 0
Study 21700755 — intervention group
Group type: EXPERIMENTAL
Intervention: Trimetazidine
Number of subjects: 44
Study 21700755 — intervention group
Group type: COMPARATOR
Intervention: Conventional therapy
Number of subjects: 44
Study 19654918 — intervention group
Group type: EXPERIMENTAL
Intervention: Coarse concentrated ambient particles (CAPs)
Number of subjects: 14
Study 19654918 — intervention group
Group type: COMPARATOR
Intervention: Filtered air
Number of subjects: 14
Study 16756416 — intervention group
Group type: COMPARATOR
Intervention: Transdermal nicotine (TN) 0 mg
Number of subjects: 128
Study 16756416 — intervention group
Group type: EXPERIMENTAL
Intervention: Transdermal nicotine (TN) 7 mg
Number of subjects: 128
Study 16756416 — intervention group
Group type: EXPERIMENTAL
Intervention: Transdermal nicotine (TN) 21 mg
Number of subjects: 128
Study 16756416 — intervention group
Group type: EXPERIMENTAL
Intervention: Transdermal nicotine (TN) 42 mg
Number of subjects: 128
Study 14770397 — intervention group
Group type: EXPERIMENTAL
Intervention: Tissue Harmonic Imaging (THI)
Number of subjects: 71
Study 14770397 — intervention group
Group type: COMPARATOR
Intervention: Fundamental Frequency Ultrasound (FFU)
Number of subjects: 71
Study 11710925 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultraviolet B exposure prior to hepatitis B vaccination
Number of subjects: 191
Study 11710925 — intervention group
Group type: COMPARATOR
Intervention: Control group (no ultraviolet B exposure)
Number of subjects: 191
Study 9509495 — intervention group
Group type: EXPERIMENTAL
Intervention: Clonidine
Number of subjects: 14
Study 9509495 — intervention group
Group type: EXPERIMENTAL
Intervention: Enalapril
Number of subjects: 14
Study 9509495 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study 8143465 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerosolized ribavirin (20 mg/mL) for 18 hrs/day for 5 days
Number of subjects: 41
Study 8143465 — intervention group
Group type: COMPARATOR
Intervention: Saline (placebo) for 18 hrs/day for 5 days
Number of subjects: 41
Study 3065506 — intervention group
Group type: EXPERIMENTAL
Intervention: Nisoldipine, 10-20 mg daily
Number of subjects: 20
Study 3065506 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 31606437 — intervention group
Group type: EXPERIMENTAL
Intervention: EVLP plus UVC perfusate irradiation
Number of subjects: 22
Study 31606437 — intervention group
Group type: COMPARATOR
Intervention: EVLP alone
Number of subjects: 22
Study 31606437 — intervention group
Group type: EXPERIMENTAL
Intervention: Sofosbuvir plus velpatasvir treatment
Number of subjects: 22
Study 31606437 — intervention group
Group type: EXPERIMENTAL
Intervention: HCV-positive donor lungs
Number of subjects: 22
Study 31606437 — intervention group
Group type: COMPARATOR
Intervention: HCV-negative donor lungs
Number of subjects: 22
Study 29596487 — intervention group
Group type: EXPERIMENTAL
Intervention: New odorant
Number of subjects: 17
Study 29596487 — intervention group
Group type: COMPARATOR
Intervention: Hex-Hex Mix
Number of subjects: 17
Study 27099485 — intervention group
Group type: EXPERIMENTAL
Intervention: Azithromycin (500 mg once a day for 3 days, then 250 mg once every 2 days for 3 months)
Number of subjects: 0
Study 27099485 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 25633769 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyberprogram 2.0
Number of subjects: 176
Study 25633769 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 176
Study 23415640 — intervention group
Group type: EXPERIMENTAL
Intervention: Orofacial manual therapy in addition to cervical manual therapy
Number of subjects: 43
Study 23415640 — intervention group
Group type: COMPARATOR
Intervention: Cervical manual therapy (usual care)
Number of subjects: 43
Study 21398433 — intervention group
Group type: EXPERIMENTAL
Intervention: NT-proBNP testing
Number of subjects: 68
Study 18978633 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylphenidate
Number of subjects: 63
Study 18978633 — intervention group
Group type: EXPERIMENTAL
Intervention: Mixed amphetamine salts
Number of subjects: 63
Study 12233988 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbamazepine (CBZ)
Number of subjects: 139
Study 12233988 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 139
Study 9585653 — intervention group
Group type: EXPERIMENTAL
Intervention: Routine care plus the intervention (n = 85)
Number of subjects: 162
Study 9585653 — intervention group
Group type: COMPARATOR
Intervention: Routine care (n = 77)
Number of subjects: 162
Study 9585653 — intervention group
Group type: EXPERIMENTAL
Intervention: Subgroup without major depression (n not specified)
Number of subjects: 162
Study 8589316 — intervention group
Group type: EXPERIMENTAL
Intervention: Dialysis Living Will
Number of subjects: 95
Study 8589316 — intervention group
Group type: EXPERIMENTAL
Intervention: Centre for Bioethics Living Will
Number of subjects: 95
Study 8589316 — intervention group
Group type: EXPERIMENTAL
Intervention: Medical Directive
Number of subjects: 95
Study 8589316 — intervention group
Group type: COMPARATOR
Intervention: Generic ADs
Number of subjects: 95
Study 2548759 — intervention group
Group type: EXPERIMENTAL
Intervention: Intracoronary injections of salbutamol
Number of subjects: 24
Study 2548759 — intervention group
Group type: COMPARATOR
Intervention: Intracoronary injections of salbutamol after practolol (beta 1-selective blockade)
Number of subjects: 24
Study 2548759 — intervention group
Group type: COMPARATOR
Intervention: Intracoronary injections of salbutamol after propranolol (beta 1- and beta 2-blockade)
Number of subjects: 24
Study 326491 — intervention group
Group type: EXPERIMENTAL
Intervention: Mefenamic acid (500 mg t.d.s.)
Number of subjects: 18
Study 326491 — intervention group
Group type: EXPERIMENTAL
Intervention: Indomethacin (25 mg q.d.s.)
Number of subjects: 18
Study 326491 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study 31090563 — intervention group
Group type: EXPERIMENTAL
Intervention: Direct oral feeding after MIE
Number of subjects: 132
Study 31090563 — intervention group
Group type: COMPARATOR
Intervention: Nil-by-mouth and tube feeding for 5 days postoperative (control)
Number of subjects: 132
Study 28440007 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluorescent hybrid zirconia abutment/crown (Test)
Number of subjects: 24
Study 28440007 — intervention group
Group type: COMPARATOR
Intervention: Conventional one-piece zirconia abutment/crown (Control)
Number of subjects: 24
Study 25723614 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard-dose adalimumab (9.48 +/- 5.61 g/mL)
Number of subjects: 192
Study 25723614 — intervention group
Group type: COMPARATOR
Intervention: Low-dose adalimumab (3.51 +/- 2.21 g/mL)
Number of subjects: 192
Study 25723614 — intervention group
Group type: EXPERIMENTAL
Intervention: Adalimumab dose escalation from every other week to weekly
Number of subjects: 192
Study 25723614 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher serum adalimumab concentrations
Number of subjects: 192
Study 25723614 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline C-reactive protein and lower baseline albumin levels
Number of subjects: 192
Study 23262179 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose hydrocortisone (0.15mg/kg)
Number of subjects: 75
Study 23262179 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose hydrocortisone (0.45mg/kg)
Number of subjects: 75
Study 23262179 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 75
Study 21768626 — intervention group
Group type: EXPERIMENTAL
Intervention: Total hip replacement
Number of subjects: 81
Study 21768626 — intervention group
Group type: COMPARATOR
Intervention: Hemiarthroplasty
Number of subjects: 81
Study 19543144 — intervention group
Group type: COMPARATOR
Intervention: Lactobacillus crispatus CTV-05 (LACTIN-V) administered by vaginal applicator at doses of 5 x 10, 1 x 10, and 2 x 10 cfu/dose for 5 consecutive days
Number of subjects: 12
Study 19543144 — intervention group
Group type: COMPARATOR
Intervention: Placebo administered by vaginal applicator
Number of subjects: 12
Study 16737494 — intervention group
Group type: EXPERIMENTAL
Intervention: Judgements on decision-making capacity based on patients' mental health status
Number of subjects: 0
Study 16737494 — intervention group
Group type: EXPERIMENTAL
Intervention: Mental health status of patients
Number of subjects: 0
Study 14744277 — intervention group
Group type: EXPERIMENTAL
Intervention: Carotid angioplasty and stenting (CAS)
Number of subjects: 85
Study 14744277 — intervention group
Group type: COMPARATOR
Intervention: Carotid endarterectomy (CEA)
Number of subjects: 85
Study 11254770 — intervention group
Group type: EXPERIMENTAL
Intervention: Paging system
Number of subjects: 143
Study 9815725 — intervention group
Group type: EXPERIMENTAL
Intervention: neoadjuvant chemoendocrine therapy (four 3‐weekly cycles of chemotherapy with mitozantrone, methotrexate (+/‐ mitomycin C), and tamoxifen)
Number of subjects: 90
Study 9815725 — intervention group
Group type: EXPERIMENTAL
Intervention: neoadjuvant chemoendocrine therapy
Number of subjects: 90
Study 7965154 — intervention group
Group type: EXPERIMENTAL
Intervention: Standardized uptake ratio (SUR)
Number of subjects: 107
Study 7965154 — intervention group
Group type: EXPERIMENTAL
Intervention: Maximum activity ratio
Number of subjects: 107
Study 7965154 — intervention group
Group type: EXPERIMENTAL
Intervention: Average activity ratio
Number of subjects: 107
Study 7965154 — intervention group
Group type: EXPERIMENTAL
Intervention: Visual interpretation
Number of subjects: 107
Study 7965154 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall accuracy
Number of subjects: 107
Study 30238870 — intervention group
Group type: EXPERIMENTAL
Intervention: 10-ml/kg fluid bolus
Number of subjects: 75
Study 30238870 — intervention group
Group type: COMPARATOR
Intervention: 20-ml/kg fluid bolus
Number of subjects: 75
Study 30238870 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 75
Study 27283780 — intervention group
Group type: EXPERIMENTAL
Intervention: Progressive Resistance Training (PRT) intervention, 3 sessions per week for 12 weeks
Number of subjects: 22
Study 24851943 — intervention group
Group type: EXPERIMENTAL
Intervention: Thoracic epidural analgesia (TEA) with continuous administration of 0.25% bupivacaine
Number of subjects: 235
Study 24851943 — intervention group
Group type: COMPARATOR
Intervention: General anaesthesia alone with intravenous analgesia (fentanyl: intubation 2 µg/kg; maintenance 0.1‐0.3 mg)
Number of subjects: 235
Study 22116669 — intervention group
Group type: EXPERIMENTAL
Intervention: Landing Error Scoring System (LESS)
Number of subjects: 5047
Study 20656955 — intervention group
Group type: EXPERIMENTAL
Intervention: Group A (with PVI)
Number of subjects: 40
Study 20656955 — intervention group
Group type: COMPARATOR
Intervention: Group B (without PVI)
Number of subjects: 40
Study 19793848 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise in neutral temperature (25 degrees C)
Number of subjects: 11
Study 19793848 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise in heat (36 degrees C)
Number of subjects: 11
Study 19793848 — intervention group
Group type: COMPARATOR
Intervention: Control (25 degrees C)
Number of subjects: 11
Study 16802555 — intervention group
Group type: EXPERIMENTAL
Intervention: Standardized exercise training for 3 weeks (14 +/- 4 days after AMI)
Number of subjects: 26
Study 16802555 — intervention group
Group type: COMPARATOR
Intervention: Control group without exercise training
Number of subjects: 26
Study 12593597 — intervention group
Group type: EXPERIMENTAL
Intervention: Nimesulide (100 mg)
Number of subjects: 30
Study 12593597 — intervention group
Group type: EXPERIMENTAL
Intervention: Naproxen (275 mg)
Number of subjects: 30
Study 12593597 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study 11783323 — intervention group
Group type: EXPERIMENTAL
Intervention: Salviae miltiorrhiza (SM) + cytosine diphosphate‐choline (CDP‐C)
Number of subjects: 51
Study 11783323 — intervention group
Group type: EXPERIMENTAL
Intervention: para‐aminomethyl benzoic acid (PAMBA) + CDP‐C
Number of subjects: 51
Study 11783323 — intervention group
Group type: COMPARATOR
Intervention: CDP‐C
Number of subjects: 51
Study 11783323 — intervention group
Group type: EXPERIMENTAL
Intervention: Salviae miltiorrhiza (SM)
Number of subjects: 51
Study 9337631 — intervention group
Group type: EXPERIMENTAL
Intervention: Interactive 2‐step theory of lexical retrieval
Number of subjects: 21
Study 9337631 — intervention group
Group type: EXPERIMENTAL
Intervention: Single‐word repetition task
Number of subjects: 21
Study 8450107 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioral Marital Therapy (BMT)
Number of subjects: 0
Study 8450107 — intervention group
Group type: EXPERIMENTAL
Intervention: Enhanced Behavioral Marital Therapy (EBMT)
Number of subjects: 0
Study 3760275 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketoconazole 2% cream
Number of subjects: 101
Study 3760275 — intervention group
Group type: COMPARATOR
Intervention: Placebo cream
Number of subjects: 101
Study 30646110 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypnosis
Number of subjects: 148
Study 30646110 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypnosis (perceived)
Number of subjects: 148
Study 30646110 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 148
Study 26956126 — intervention group
Group type: COMPARATOR
Intervention: Heat-killed LP28
Number of subjects: 62
Study 25008579 — intervention group
Group type: EXPERIMENTAL
Intervention: Soy-protein diet (30 g/d soy protein)
Number of subjects: 15
Study 25008579 — intervention group
Group type: EXPERIMENTAL
Intervention: Soy-protein diet
Number of subjects: 15
Study 25008579 — intervention group
Group type: COMPARATOR
Intervention: Mixed-protein diet
Number of subjects: 15
Study 22811452 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational session with relatives, including distribution of 5 posters about stroke signs and instructions to call 911.
Number of subjects: 60
Study 22811452 — intervention group
Group type: COMPARATOR
Intervention: Control group (usual discharge plan).
Number of subjects: 60
Study 20207926 — intervention group
Group type: EXPERIMENTAL
Intervention: Sitting position for PEF measurement
Number of subjects: 211
Study 20207926 — intervention group
Group type: COMPARATOR
Intervention: Standing position for PEF measurement
Number of subjects: 211
Study 18806203 — intervention group
Group type: EXPERIMENTAL
Intervention: MCS providing 15 mmHg
Number of subjects: 40
Study 18806203 — intervention group
Group type: EXPERIMENTAL
Intervention: MCS providing 20 mmHg
Number of subjects: 40
Study 18806203 — intervention group
Group type: EXPERIMENTAL
Intervention: MCS providing <10 mmHg
Number of subjects: 40
Study 18806203 — intervention group
Group type: EXPERIMENTAL
Intervention: MCS providing >19 mmHg
Number of subjects: 40
Study 18806203 — intervention group
Group type: EXPERIMENTAL
Intervention: MCS providing 4-9 mmHg (mean 7.3)
Number of subjects: 40
Study 18806203 — intervention group
Group type: EXPERIMENTAL
Intervention: MCS providing 12-18 mmHg (mean 14.9)
Number of subjects: 40
Study 18806203 — intervention group
Group type: EXPERIMENTAL
Intervention: MCS providing 18-22 mmHg (mean 19.5)
Number of subjects: 40
Study 15709987 — intervention group
Group type: EXPERIMENTAL
Intervention: CDP571 (20 mg/kg at week 0 and 10 mg/kg at week 8)
Number of subjects: 71
Study 15709987 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 71
Study 11792327 — intervention group
Group type: EXPERIMENTAL
Intervention: Direct stenting
Number of subjects: 411
Study 11792327 — intervention group
Group type: COMPARATOR
Intervention: Conventional stenting with predilation
Number of subjects: 411
Study 9934298 — intervention group
Group type: EXPERIMENTAL
Intervention: Practice Video Assessment (PVA)
Number of subjects: 90
Study 9934298 — intervention group
Group type: COMPARATOR
Intervention: Multiple-Station Examination (MSE)
Number of subjects: 90
Study 8624225 — intervention group
Group type: EXPERIMENTAL
Intervention: Triclosan-copolymer mouthrinse
Number of subjects: 100
Study 8624225 — intervention group
Group type: COMPARATOR
Intervention: Placebo mouthrinse
Number of subjects: 100
Study 2184711 — intervention group
Group type: EXPERIMENTAL
Intervention: Mammacare group
Number of subjects: 300
Study 2184711 — intervention group
Group type: EXPERIMENTAL
Intervention: Traditional group
Number of subjects: 300
Study 2184711 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 300
Study 6157197 — intervention group
Group type: EXPERIMENTAL
Intervention: Debrisan (dextranomer)
Number of subjects: 100
Study 6157197 — intervention group
Group type: COMPARATOR
Intervention: Control (standard treatment)
Number of subjects: 100
Study 30794101 — intervention group
Group type: EXPERIMENTAL
Intervention: S100B
Number of subjects: 566
Study 30794101 — intervention group
Group type: EXPERIMENTAL
Intervention: GFAP
Number of subjects: 566
Study 30794101 — intervention group
Group type: EXPERIMENTAL
Intervention: UCH-L1
Number of subjects: 566
Study 30794101 — intervention group
Group type: EXPERIMENTAL
Intervention: SBDP150
Number of subjects: 566
Study 30794101 — intervention group
Group type: COMPARATOR
Intervention: Baseline patient variables/characteristics
Number of subjects: 566
Study 27029918 — intervention group
Group type: EXPERIMENTAL
Intervention: Iron-enriched yeast (2.5 mg 58Fe)
Number of subjects: 32
Study 27029918 — intervention group
Group type: COMPARATOR
Intervention: Ferrous sulfate (2.5 mg 57Fe)
Number of subjects: 32
Study 27029918 — intervention group
Group type: EXPERIMENTAL
Intervention: Iron-enriched yeast (2.5 mg 58Fe) with bread and butter
Number of subjects: 32
Study 27029918 — intervention group
Group type: COMPARATOR
Intervention: Ferrous sulfate (2.5 mg 57Fe) with bread and butter
Number of subjects: 32
Study 27029918 — intervention group
Group type: EXPERIMENTAL
Intervention: Iron-enriched yeast
Number of subjects: 32
Study 27029918 — intervention group
Group type: COMPARATOR
Intervention: Ferrous sulfate
Number of subjects: 32
Study 25836918 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydroxytyrosol 5 mg/d
Number of subjects: 0
Study 25836918 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydroxytyrosol 25 mg/d
Number of subjects: 0
Study 25836918 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 25836918 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydroxytyrosol (both doses)
Number of subjects: 0
Study 24050512 — intervention group
Group type: EXPERIMENTAL
Intervention: Esomeprazole (20 mg b.i.d), tripotassium dicitrate bismuthate (300 mg q.i.d), metronidazole (500 mg t.i.d), and tetracycline (500 mg q.i.d) (EBMT)
Number of subjects: 648